|
[Hypertension] |
July 3(Fri.) 09:30-11:00 Rm. 102 |
| BP Measurement |
| Chairperson(s) | 채성철, 편욱범 |
| Panel | 유승기, 임상현, 조은주 |
| 09:30-09:50 |
Office BP Measurement in Non-mercury Era
|
신진호 / 한양의대 |
| 09:50-10:10 |
Automated Office BP (AOBP)
|
박성하 / 연세의대 |
| 10:10-10:30 |
Out-of-office BP
|
이해영 / 서울의대 |
| 10:30-10:50 |
New Technology to Measure BP
|
서종모 / 서울대학교 |
| 10:50-11:10 |
Discussion |
|
[Cross Specialty: Gastroenterology & Intervention] |
July 3(Fri.) 09:30-11:00 Rm. 103 |
| Bleeding Issues in Cardiovascular Disease |
| Chairperson(s) | 김기식, 권현철 |
| Panel | 김병극, 박재형, 임영효, 한승환 |
| 09:30-09:50 |
How to Identify High Bleeding Risk Patients?
|
정영훈 / 경상의대 |
| 09:50-10:10 |
Mechanisms and Treatment of Gastrointestinal Bleeding after Antithrombotic Therapy
|
국형돈 / 고려의대 |
| 10:10-10:30 |
Management and Prevention of Stress Ulcers in the Intensive Care Unit
|
이왕수 / 중앙의대 |
| 10:30-10:50 |
What Cardiologists Need to Know about Hematologic Bleeding Disorders!
|
변자민 / 서울의대 |
| 10:50-11:00 |
Discussion |
|
[Myocardial Infarction 1] |
July 3(Fri.) 09:30-11:00 Rm. 203 |
| Pharmacotherapy in AMI; Meet the Expert |
| Chairperson(s) | 정명호, 박헌식 |
| Panel | 김원, 박종선, 배장환, 안영근, 이봉렬, 장기육 |
| 09:30-09:50 |
My Ideal Antithrombotic Strategy after AMI
|
박용휘 / 경상의대 |
| 09:50-10:10 |
From ACE Inhibition to ARNI; My Approach in Patients with AMI with Severe LV Dysfunction
|
윤창환 / 서울의대 |
| 10:10-10:30 |
Statin, Ezetimibe, PCSK-9 Inhibitor: My Approach for Optimal LDL-C Reduction Following AMI
|
이상엽 / 충북의대 |
| 10:30-10:50 |
My Glycemic Strategies to Reduce Risk Following AMI in Diabetes
|
김민철 / 전남의대 |
| 10:50-11:00 |
Discussion |
|
[교육수련위원회 주관 세션] |
July 3(Fri.) 09:30-11:00 Rm. 205 |
| 순환기 내과 전임의 수련 개선 포럼 |
| Chairperson(s) | 나승운, 고영국 |
|
외부 Panel : 강동오, 라모니 |
|
지정토론자: 김진진, 박상호, 이진배, 장세용, 진정연, 최철웅 |
| 14:50-15:10 |
순환기 전임의 및 분과장 설문조사 결과 요약
|
김진배 / 경희의대 |
| 15:10-15:30 |
국내 전임의 수련 모범사례
|
김미나 / 고려의대 |
| 15:30-15:50 |
해외 전임의 수련 시스템 소개
|
한성욱 / 계명의대 |
| 15:50-16:20 |
Discussion |
|
[Cross Specialty: Neurology & Intevention & Imaging] |
July 3(Fri.) 11:10-12:40 Rm. 102 |
| PFO Closure, Embolic Cerebral Infarction during Intervention |
| Chairperson(s) | 김종성, 임도선, 박태호 |
| Panel | 박경우, 장준영, 황양하 |
| 11:10-11:25 |
Stroke in Patients Undergoing Endovscular Procedure: Incidence, Predictors, Outcome and Therapeutic Options
|
이준 / 영남의대 |
| 11:25-11:40 |
Which PFO Should Be Treated or Not Treated?: Optimal Indication with Imaging Concept
|
이승아 / 울산의대 |
| 11:40-11:55 |
My Best or Worst Cases with Device Closure for PFO
|
서정원 / 서울의대 |
| 11:55-12:10 |
Neurological Complications with TAVR and Its Prevention
|
강도윤 / 울산의대 |
| 12:10-12:25 |
Stroke Following Percutaneous Coronary Intervention: Influence of Access Site Choice and Procedural Consideration
|
황양하 / 경북의대 |
| 12:25-12:40 |
Discussion |
|
[Women Heart Disease] |
July 3(Fri.) 11:10-12:40 Rm. 103 |
| Cardio-metabolic Disease in Women |
| Chairperson(s) | 김명아 |
| Panel | 박용현, 변영섭, 신미승, 윤현주 |
| 11:10-11:30 |
Obesity and Heart
|
김현진 / 한양의대 |
| 11:30-11:50 |
Healthy Diet for Heart
|
신성희 / 인하의대 |
| 11:50-12:10 |
Sleep and Heart
|
나진오 / 고려의대 |
| 12:10-12:30 |
Physical Exercise on Cardio-metabolic Outcomes
|
박혁진 / 전남의대 |
| 12:30-12:40 |
Discussion |
|
[Special Session] COVID-19 & Cardiovascular Disease |
July 3(Fri.) 11:10-12:40 Rm. 202 |
| COVID-19 Pandemic and Cardiovascular Disease |
| Chairperson(s) | 백상홍, 권현철 |
| Panel | 권기태, 박찬석, 정동식, 정중화 |
| 11:10-11:30 |
Anatomy of the Pandemic
|
권유욱 / 서울의대 |
| 11:30-11:50 |
Viral Infection and the Heart
|
김인철 / 계명의대 |
| 11:50-12:10 |
Cardiovascular Diseases as Risk Factors of COVID-19: Fact or Misinterpretation?
|
이장훈 / 경북의대 |
| 12:10-12:30 |
RAAS and COVID-19 Conundrum - Friend or Foe?
|
박성하 / 연세의대 |
| 12:30-12:40 |
Discussion |
|
[Adult Congenital Heart Disease 1] |
July 3(Fri.) 11:10-12:40 Rm. 203 |
| Should We Close This Small Hole? - Why, When, and How? |
| Chairperson(s) | 송재관 |
| Panel | 박정랑, 신유림, 양동헌, 이주희 |
| 11:10-11:28 |
Small Subarterial VSD with Mild AR
|
은영민 / 연세의대 |
| 11:28-11:46 |
Small ASD with Moderate Pulmonary Hypertension
|
박재형 / 충남의대 |
| 11:46-12:04 |
Small PDA with/without Murmur
|
장기영 / 고려의대 |
| 12:04-12:40 |
Discussion |
|
[English Session]
[Epidemiology] |
July 3(Fri.) 11:10-12:40 Rm. 205 |
| Psycho-social Risk Factors of Cardiovascular Disease |
| Chairperson(s) | Jang-Whan Bae, Hyeon Chang Kim |
| Panel | Jin Yong Hwang |
| 11:10-11:40 |
Psychosocial Risk Factors of Cardiovascular Disease in Japan
|
Hiroyasu Iso / Osaka University, Japan |
| 11:40-11:55 |
Depression and Cardiovascular Disease Result in Epidemidogy
|
Sun Jae Jung / Yonsei Univ., Korea |
| 11:55-12:10 |
Job-stress and the Risk of Cardiovascular Disease
|
Hyung Ryul Kim / Catholic Univ., Korea |
| 12:10-12:25 |
Socioeconomic Status and Cardiovascular Disease
|
Jidong Sung / Sungkyunkwan Univ., Korea |
| 12:25-12:40 |
Discussion |
|
Scientific Session [Amgen] |
July 3(Fri.) 12:45-13:25 Rm. 102 |
| An Ideal Lipid Management with Evolocumab in Very High-risk Patients |
| Chairperson(s) | 구본권, 배장환 |
| 12:45-13:00 |
How to Use Evolocumab in Patients with FH
|
이상학 / 연세의대 |
| 13:00-13:15 |
Guideline Based Intensive Lipid Lowering Treatment in ASCVD Patients
|
김원 / 경희의대 |
| 13:15-13:25 |
Discussion |
|
Scientific Session [MSD] |
July 3(Fri.) 12:45-13:25 Rm. 103 |
| Protecting Coronary Patients in the Future |
| Chairperson(s) | 현민수 |
| 12:45-13:15 |
The Benefit of Ezetimibe/atorvastatin Combination Therapy in Coronary Risk Patients with Hypercholesterolemia
|
박경우 / 서울의대 |
| 13:15-13:25 |
Discussion |
|
Scientific Session [Samjin] |
July 3(Fri.) 12:45-13:25 Rm. 105 |
| Recent Updates on Cardiovascular Disease Management |
| Chairperson(s) | 한규록 |
| 12:45-13:05 |
Long-term Outcomes of Clopidogrel in ACS
|
이봉기 / 강원의대 |
| 13:05-13:25 |
All NOACs Are Same?
|
이광노 / 아주의대 |
|
Scientific Session [Bayer] |
July 3(Fri.) 12:45-13:25 Rm. 203 |
| Rivaroxaban, One Step Further for Patient Protection |
| Chairperson(s) | 김영대, 최기준 |
| 12:45-13:05 |
Considering Optimal Dose of Rivaroxaban for Specific Patients in Korea
|
최의근 / 서울의대 |
| 13:05-13:25 |
Recent Advances in Treatment of High Risk CAD and PAD
|
김병극 / 연세의대 |
|
Scientific Session [Boryung] |
July 3(Fri.) 12:45-13:25 Rm. 205 |
| What's New in CVD Risk Management |
| Chairperson(s) | 전은석, 오용석 |
| 12:45-13:05 |
Future Directions for Treatment into LDL Lowering and Antihypertensive
|
이해영 / 서울의대 |
| 13:05-13:25 |
Outcomes after Use of Low-dose NOAC in Patients with AF
|
김태훈 / 연세의대 |
|
Diamond Session [Pfizer/BMS] |
July 3(Fri.) 12:45-13:25 Rm. 300C |
| Strategies to Optimize Management of ASCVD |
| Chairperson(s) | 장기육, 김대혁 |
| 12:45-13:05 |
Broaden Understanding Why Atorvastatin Is Enough to Control the LDL-C and Secondary Prevention for ASCVD
|
김원장 / 차의대 |
| 13:05-13:25 |
What Is the Optimal Treatment Solution for Stroke Prevention in Elderly Population?
|
김성환 / 가톨릭의대 |
|
[Memorial Lecture] |
July 3(Fri.) 13:25-13:40 Rm. 300C |
| Chairperson(s) | 김기식 |
| 13:40-13:55 |
윤해병 교수님 회고
|
윤호중 / 가톨릭의대 |
| 13:55-14:15 |
Aspirin Free DAPT (TICO Trial)
|
장양수 / 연세의대 |
| 14:15-14:30 |
Discussion |
|
[Myocardial Infarction 2] |
July 3(Fri.) 14:30-16:00 Rm. 203 |
| STEMI Challenges in 2020 |
| Chairperson(s) | 김효수 |
| Panel | 김웅, 나득영, 서존, 조진만, 황진용 |
| 14:30-14:50 |
How to Expedite Coronary Artery Reperfusion: Walk-in, Arrival by Ambulance, Inter-hospital Transfer
|
이장훈 / 경북의대 |
| 14:50-15:10 |
Evidence-based Optimal Antithrombotic Therapy before, during, and after Primary PCI for STEMI
|
박근호 / 조선의대 |
| 15:10-15:30 |
No Reflow & Intraprocedural Arrest during Primary PCI: How to Prevent It and How to Fix It
|
허정호 / 고신의대 |
| 15:30-15:50 |
How to Manage ECMO in CCU after Cardiogenic Shock: from Start to Weaning
|
양정훈 / 성균관의대 |
| 15:50-16:00 |
Discussion |
|
[Basic Research 1] |
July 3(Fri.) 14:30-16:00 Rm. 205 |
| Understanding Basics of Cardiovascular Research |
| Chairperson(s) | 안영근, 권기환 |
| Panel | 김용숙, 민필기, 임상현, 홍순준 |
| 14:30-14:50 |
디지털 PCR의 기초와 혈액 및 조직을 이용한 분석방법
|
박진영 / BioRad |
| 14:50-15:10 |
Preclinical Study Using Large Animal: Application of Pig
|
임경섭 / 한국생명공학연구원 |
| 15:10-15:30 |
심혈관연구를 위한 신소재 활용
|
이재영 / 광주과학기술원 |
| 15:30-16:00 |
Discussion |
|
[Adult Congenital Heart Disease 2] |
July 3(Fri.) 16:10-17:40 Rm. 203 |
| Pulmonary Vasodilator in Adult Congenital Heart Disease |
| Chairperson(s) | 손대원, 박승우 |
| Panel | 박준빈, 윤현주, 이미래, 장우성 |
| 16:10-16:28 |
Fontan Circulation and Pulmonary Vasodilator
|
강이석 / 성균관의대 |
| 16:28-16:46 |
Pulmonary Vasodilators in Non-Eisenmenger CHD Patients
|
김경희 / 세종병원 |
| 16:46-17:04 |
Eisenmenger Syndrome and Pulmonary Vasodilator
|
최정현 / 부산의대 |
| 17:04-17:22 |
Pulmonary Vasodilator during Postoperatative Period
|
김여향 / 경북의대 |
| 17:22-17:40 |
Discussion |
|
[Basic Research 2] |
July 3(Fri.) 16:10-17:40 Rm. 205 |
| Strategies for Cardiovascular Research |
| Chairperson(s) | 조명찬, 정진옥 |
| Panel | 김민철, 박훈준, 배장환, 이찬주, 팽진철 |
| 16:10-16:30 |
기초연구를 위한 연구 포트폴리오 만들기
|
최종일 / 고려의대 |
| 16:30-16:50 |
특허검색 및 활용전략
|
송영훈 / 특허정보진흥센터 |
| 16:50-17:10 |
심혈관 질환 연구를 위한 HIRA 빅데이터의 이해와 활용방법
|
권의정 / 건강보험심사평가원 |
| 17:10-17:40 |
Discussion |
|
[Cross Specialty: Cardiogenic Shock] |
July 4(Sat.) 09:00-10:30 Rm. 102 |
| Current and Future Perspectives in Cardiogenic Shock |
| Chairperson(s) | 권현철, 강석민 |
| Panel | 안철민, 양정훈, 장우진 |
| 09:00-09:20 |
Is Coronary Revascularization in HF Necessary? If Yes, When and Which One(Surgical vs. Percutaneous Approach)
|
이장훈 / 경북의대 |
| 09:20-09:40 |
Limit of Medical Tx and MCS in Cardiogenic Shock. When to Start and Which One to Start?
|
서석민 / 가톨릭의대 |
| 09:40-10:00 |
Optimal Timing for Durable Cardiac Replacement Therapy
|
최진오 / 성균관의대 |
| 10:00-10:20 |
What Are the Hidden Challenges That Intensivists Encoutner in ICU?
|
김민석 / 울산의대 |
| 10:20-10:30 |
Discussion |
|
[Vascular] |
July 4(Sat.) 09:00-10:30 Rm. 105 |
| Early Detection of Vascular Disease, Keeping Vascular Health |
| Chairperson(s) | 하종원, 정해억 |
| Panel | 이찬주, 임상현, 조은주 |
| 09:00-09:20 |
Old and New Biomarkers of Vascular Risk and Inflammation
|
이해영 / 서울의대 |
| 09:20-09:40 |
Recent Update of Coronary Calcium Score
|
조익성 / 연세의대 |
| 09:40-10:00 |
Carotid Mechanical Function Beyond IMT and Plaques
|
김성애 / 한림의대 |
| 10:00-10:20 |
Venous Function Beyond Deep Vein Thrombosis
|
심지영 / 연세의대 |
| 10:20-10:30 |
Discussion |
|
[KSCP-KSC Joint Session 1] |
July 4(Sat.) 09:00-10:30 Rm. 202 |
| COVID-19 and Cardiovascular Disease |
| Chairperson(s) | 박성하, 김현창 |
| Panel | 김신우, 김창수, 박윤수, 하진 |
| 09:00-09:20 |
중국과 한국에서의 COVID-19 역학과 임상증상
|
김동현 / 한림의대 |
| 09:20-09:40 |
COVID-19가 심혈관계에 미치는 영향 (ACE2, Acute Cardiac Injury, Chronic Cardiovascular Damage, Pre-existing CVD)
|
배장환 / 충북의대 |
| 09:40-10:00 |
여행 제한이 COVID-19의 전파에 미치는 영향
|
옥진주 / 가톨릭의대 |
| 10:00-10:30 |
Discussion |
|
[Cardio-Oncology] |
July 4(Sat.) 09:00-10:30 Rm. 205 |
| Current Status of Cardio-Oncology Research in Korea |
| Chairperson(s) | 민창기, 신미승 |
| Panel | 손일석 |
| 09:00-09:15 |
Multimodal Imaging in the Era of Cardio-oncology: An Additional Role of Myocardial Work
|
최자연 / 고려의대 |
| 09:15-09:30 |
Cardiovascular Radiation Theraphy
|
김미나 / 고려의대 |
| 09:30-09:45 |
Recent Research Interests in Cardio-oncology: Medical Oncologists Perspectives
|
이윤규 / 성균관의대 |
| 09:45-10:00 |
Carfilzomib-Induced Cardiovascular Events
|
이유진 / 울산의대 |
| 10:00-10:30 |
Discussion |
|
[Cross Specialty: Arrhythmia & Heart Failure & Intervention] |
July 4(Sat.) 09:00-10:30 Rm. 300C |
| What Is Optimal Care for Post-MI HF Patients? |
| Chairperson(s) | 최동주, 한규록, 오용석 |
| Panel | 김성은, 정보영 |
| 09:00-09:12 |
Post MI HF Primer: Scope, Epidemiology and Novel Approach
|
이상언 / 울산의대 |
| 09:12-09:24 |
Post MI HF: Who Develop Heart Failure and How to Prevent It?
|
윤창환 / 서울의대 |
| 09:24-09:36 |
Optimal Care for Post-MI HF Patients: HF Physician's Cases and Perspectives
|
유병수 / 연세원주의대 |
| 09:36-09:48 |
Post MI HF: Prevention of Sudden Cardiac Death
|
김태훈 / 연세의대 |
| 09:48-10:00 |
Optimal Strategy of Antithrombotic Treatment in Patients with AF and Coronary Artery Disease
|
황유미 / 가톨릭의대 |
| 10:00-10:30 |
Discussion |
|
[Health Policy] |
July 4(Sat.) 10:40-12:10 Rm. 102 |
| 심혈관질환의 국내 관리현황 및 보건정책 개선 방향 |
| Chairperson(s) | 오동진, 정명호 |
| Panel | 김병옥, 김상현, 김원, 최승혁 |
| 10:40-10:55 |
급성심근경색증 및 응급질환의 국내 관리 현황
|
김영택 / 충남의대 |
| 10:55-11:10 |
심뇌혈관질환 적정치료(질 개선)와 관리를 위한 정책 방향
|
배장환 / 충북의대 |
| 11:10-11:25 |
권역심뇌혈관센터 정비 및 기능활성화 방안
|
윤창환 / 서울의대 |
| 11:25-11:40 |
심혈관질환관리 종합계획에 따른 국가통계생산체계 구축 방안
|
하진 / 질병관리본부 |
| 11:40-12:10 |
Discussion |
|
[Imaging] |
July 4(Sat.) 10:40-12:10 Rm. 103 |
| New Techniques and Trends in Cardiovascular Imaging |
| Chairperson(s) | 송재관, 정정임 |
| Panel | 이승표, 이종민, 정성호, 추기석, 최의영 |
| 10:40-11:00 |
New Techniques in CT/MRI : Dual Energy & AI
|
황성호 / 고려의대 |
| 11:00-11:20 |
New Techniques in Echocardiography : Strain & Vortex
|
조익성 / 연세의대 |
| 11:20-11:40 |
3D Printing and Virtual Reality in Cardiovascular Imaging
|
양동현 / 울산의대 |
| 11:40-12:10 |
Discussion |
|
[KSCP-KSC Joint Session 2] |
July 4(Sat.) 10:40-12:10 Rm. 202 |
| Sports Cardiology, "The Start of Something Special" |
| Chairperson(s) | 백상홍, 강석민 |
| Panel | 이찬주, 정인현 |
| 10:40-11:00 |
Cardiovascular Evaluation before Competitive Sports
|
성지동 / 성균관의대 |
| 11:00-11:20 |
Can Too Much Exercise Be Harmful to the Heart?
|
제세영 / 서울시립대 |
| 11:20-11:40 |
Management of Cardiovascular Disease in Athlete, Considering Therapeutic Use Exemption (TUE)
|
김진배 / 경희의대 |
| 11:40-12:00 |
Cardiac Adaptation to Exercise Training
|
김계훈 / 전남의대 |
| 12:00-12:10 |
Discussion |
|
[Smart Health] |
July 4(Sat.) 10:40-12:10 Rm. 203 |
| Smart Hospital Care |
| Chairperson(s) | 김용진, 이상철 |
| Panel | 강현재, 박경민, 박성하 |
| 10:40-11:00 |
의사-환자간 소통을 위한 플랫폼 구축과 사례
|
조재형 / 가톨릭의대 |
| 11:00-11:20 |
보험업의 디지털 헬스케어-당뇨병 관리
|
최두아 / 휴레이포지티브 |
| 11:20-11:40 |
Emerging the importance of Real World Evidence: From “Nice to Have” to “Must Have”
|
김정애 / IQVIA |
| 11:40-12:00 |
중환자실 생체 정보를 활용한 위험도 사전 예측
|
윤덕용 / 아주의대 |
| 12:00-12:10 |
Discussion |
|
Scientific Session [Hanmi] |
July 4(Sat.) 12:15-12:55 Rm. 102 |
| Optimal Therapy to Manage CV Risk in Hypertension and Dyslipidemia |
| Chairperson(s) | 편욱범 |
| 12:15-12:35 |
Maximizing CVD Prevention by Intensive Antihypertensive Combination Therapy
|
김응주 / 고려의대 |
| 12:35-12:55 |
Benefits of Ezetimibe Add-on Therapy for CVD Prevention
|
최성훈 / 한림의대 |
|
Scientific Session [Pfizer/BMS] |
July 4(Sat.) 12:15-12:55 Rm. 103 |
| Advanced Management of Venous Thromboembolism and Hyperlipidemia |
| Chairperson(s) | 안영근, 정보영 |
| 12:15-12:35 |
How to Approach Anticoagulation in Atrial Fibrillation Patient with Renal Impairment
|
김성환 / 가톨릭의대 |
| 12:35-12:55 |
If It’s All Just LDL-C Reduction, Shouldn’t We Clarify Many Faces of Atorvastatin
|
이장훈 / 경북의대 |
|
Scientific Session [Novartis] |
July 4(Sat.) 12:15-12:55 Rm. 105 |
| ARNI: From Admission to Post-Discharge Management |
| Chairperson(s) | 안태훈, 최동주 |
| 12:15-12:35 |
Pre-discharge Management for Better HF Outcome with ARNI
|
조현재 / 서울의대 |
| 12:35-12:55 |
Post-discharge Management with ARNI to Reverse Cardiac Remodeling
|
박만원 / 가톨릭의대 |
|
Scientific Session [Takeda/Dong-A ST] |
July 4(Sat.) 12:15-12:55 Rm. 202 |
| New Insights and Implications of BP Lowering |
| Chairperson(s) | 강덕현, 강석민 |
| 12:15-12:35 |
Differential Benefits of the Newest ARB in Hypertension
|
정중화 / 조선의대 |
| 12:35-12:55 |
A+C vs A+D, What Is Better as a Combination Therapy?
|
박성하 / 연세의대 |
|
Scientific Session [Daiichisankyo/Daewoong] |
July 4(Sat.) 12:15-12:55 Rm. 203 |
| Achieving Best Outcome for Patients with Cardiovascular Disease with Edoxaban and Olmesartan |
| Chairperson(s) | 박창규, 임세중 |
| 12:15-12:35 |
EDOSURE - Edoxaban Provide Physicians and Patients Across the World with Greater Treatment Assurance
|
홍그루 / 연세의대 |
| 12:35-12:55 |
Approaches for the Medical Management of Resistant Hypertension
|
이찬주 / 연세의대 |
|
Scientific Session [Lilly/Boehringer Ingelheim] |
July 4(Sat.) 12:15-12:55 Rm. 205 |
| A Shift in a Continuum on the Management of Cardiovascular Disease and Type 2 Diabetes |
| Chairperson(s) | 정명호, 김효수 |
| Panel | 김원, 전동운 |
| 12:15-12:35 |
The Value of Empagliflozin and Its CVOT alongside with a Shift in T2D Treatment Guideline
|
김중선 / 연세의대 |
| 12:35-12:55 |
Discussion |
|
Diamond Session [Amgen] |
July 4(Sat.) 12:15-12:55 Rm. 300C |
| Application of PCSK9 Inhibitor for ASCVD Patients in Korea |
| Chairperson(s) | 홍범기 |
| 12:15-12:30 |
The Importance of Earlier and Lower LDL-C Reduction in ASCVD Patients
|
김병극 / 연세의대 |
| 12:30-12:45 |
How to Apply Repatha Reimbursement in ASCVD Patients?
|
이원재 / 서울의대 |
| 12:45-12:55 |
Discussion |
|
[Cardiac Surgery] |
July 4(Sat.) 13:10-14:40 Rm. 203 |
| Comprehensive Surgeries and Endovascular Repair of Aortic Disease in Current Era |
| Chairperson(s) | 성기익 |
| Panel | 이치훈, 허운 |
| 13:10-13:25 |
Cerebral Proctection during an Arch Surgery
|
정수련 / 성균관의대 |
| 13:25-13:40 |
Current Options for the Treatment of Aortic Arch Aneurysm: Open or Hybrid Endovascular Repair?
|
최재웅 / 서울의대 |
| 13:40-13:55 |
Organ Protection during a Descending Aorta Surgery
|
김근직 / 경북의대 |
| 13:55-14:10 |
Endovascular Repair of Type B Aortic Dissection
|
송석원 / 연세의대 |
| 14:10-14:40 |
Discussion |
|
|
|
|
[의료정보위원회 주관 세션] |
July 4(Sat.) 14:50-16:20 Rm. 105 |
| 빅데이터 이렇게 연구해서 활용한다! |
| Chairperson(s) | 정욱진, 윤덕용 |
| Panel | 김대희, 김지희, 김현창, 박성미 |
| 14:50-15:10 |
의료빅데이터를 활용한 약물감시 적용 사례
|
이수현 / 건양의대 |
| 15:10-15:30 |
Claim Data 구조의 이해와 활용-Claim Data(HIRA, NHIS)를 활용한 연구
|
경대성 / 한미약품 |
| 15:30-15:50 |
Patient-Generated Health Record 기반 맞춤 약물치료
|
강민규 / 충북의대 |
| 15:50-16:20 |
Discussion |
|
[BESCO-KSC Joint Session] |
July 4(Sat.) 14:50-16:20 Rm. 205 |
| AIM (AI in Medicine) Technology in Practice |
| Chairperson(s) | 이상형, 심은보 |
| Panel | 박형복, 허란 |
| 14:50-15:10 |
Development of AI-based Super-Resolution Ultrasound Flow Imaging Technique
|
이상준 / 포항공과대학교 |
| 15:10-15:30 |
Coronary Artery Diagnosis Decision Using Advanced Machine Learning Technique
|
김영우 / 연세대학교 |
| 15:30-16:00 |
Practical Guide to Clinical Data Analysis with AI
|
유진규 / AItrics |
| 16:00-16:20 |
Discussion |
대한심장학회
대한부정맥학회
대한소아심장학회
대한심부전학회
대한심혈관중재학회
심장대사증후군학회
한국심초음파학회
한국지질·동맥경화학회